跳至主要内容
临床试验/CTRI/2022/02/040276
CTRI/2022/02/040276已完成未知

A study to evaluate the effect of Alpha lipoic acid on inhibition of platelet aggregation in diabetic neuropathy patients on Gabapentin or Pregabalin

Indian council of Medical Research0 个研究点目标入组 52 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
52

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Type 2 diabetic patients of either sex aged between 30 - 65 years
  • 2.Duration of diabetes >10 ± 5 years
  • 3.Symptomatic diabetic polyneuropathy patients with VPT value more than 15V
  • 4.HbA1c < 10%
  • 5.Patients on stable dose of antidiabetic drug or combination of Metformin + sulphonyl urea +
  • DPP4 Inhibitors for the past 3 months
  • 6.Patients on stable dose of Gabapentin 300 mg BD or Pregabalin 75mg BD for past 3 months
  • 7.Serum creatinine < 2 mg/dl

排除标准

  • 1.Any other conditions causing neuropathic pain
  • 2.History of hypersensitivity to alpha Lipoic acid
  • 3.Patients on antiplatelet drugs
  • 4.Patients receiving other antioxidants
  • 5.Patients with active cardiovascular disease
  • 6.Patients with liver dysfunction (ALT / AST > 3 times the upper limit of normal)
  • 7.Patients with clinically significant skin disease
  • 8.Pregnant and lactating women.

研究者

相似试验